Publications by authors named "Zhenkui Pan"

Claim this Profile
D
Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer.
Feng Zhu, Ran Zhong, Feng Li, Caichen Li, Noren Din, Zhenkui Pan

Transl Lung Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence.
Haoxin Peng, Xiangrong Wu, Ran Zhong, Tao Yu, Xiuyu Cai, Zhenkui Pan

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China.
Caichen Li, Jun Liu, Zhanhong Xie, Feng Zhu, Bo Cheng, Zhenkui Pan

Ther Adv Med Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-(L)1 inhibitors vs. chemotherapy vs. their combination in front-line treatment for NSCLC: An indirect comparison.
Hengrui Liang, Zhichao Liu, Xiuyu Cai, Zhenkui Pan, Difei Chen

Int J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis.
Yi Zhao, Jingting Liu, Xiuyu Cai, Zhenkui Pan, Jun Liu

BMJ· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer.
Zhichao Liu, Hengrui Liang, Jie Lin, Xiuyu Cai, Zhenkui Pan

Lung Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition.
Wenhua Liang, Minzhang Guo, Zhenkui Pan, Xiuyu Cai, Caichen Li

Cancer Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.
Qihua He, Peiling Xin, Mingzhe Zhang, Si Jiang, Jianrong Zhang, Zhenkui Pan

Transl Lung Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer.
Hengrui Liang, Zhenkui Pan, Xiuyu Cai, Wei Wang, Chengye Guo

Transl Lung Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer.
Hengrui Liang, Zhenkui Pan, Xiuyu Cai, Wei Wang, Chengye Guo

Transl Lung Cancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis.
Hengrui Liang, Zhenkui Pan, Wei Wang, Chengye Guo, Difei Chen

J Thorac Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.
Zhen-Kui Pan, Feng Ye, Xuan Wu, Han-Xiang An, Jing-Xun Wu

J Thorac Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.
Dan-Hong Li, Zhen-Kui Pan, Feng Ye, Han-Xiang An, Jing-Xun Wu

Tumour Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[K-RAS gene mutations in patients with non-small cell lung cancer].
Yang Zhang, Zhenkui Pan, Xing Zhang, Fei Xu, Li Zhang

Zhongguo Fei Ai Za Zhi· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].
Yang Zhang, Li Zhang, Fei Xu, Zhi-Qiang Wang, Hong-Yun Zhao, Zhen-Kui Pan

Ai Zheng· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tissue microarray analysis of HER2 protein expression in patients with non-small cell lung cancer].
Ning Li, Bo Wang, Xing Zhang, Zhenkui Pan, Fei Xu

Zhongguo Fei Ai Za Zhi· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].
Zhen-Kui Pan, Li Zhang, Xing Zhang, Xin Wang, Ning Li

Ai Zheng· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
Li Zhang, Yang Zhang, Ning Li, Fei Xu, Zhen-Kui Pan

Ai Zheng· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis